Blueshift Asset Management’s Cardlytics CDLX Stock Holding History

Blueshift Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-339	Closed	-$224K	–	854
2021 Q4	$224K	Buy	+339	New	+$259K	0.02%	724
2021 Q1	–	Sell	-260	Closed	-$370K	–	869
2020 Q4	$370K	Buy	+260	New	+$277K	0.04%	477

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Blueshift Asset Management's CDLX Position: Q1 2022 in Review

Blueshift Asset Management sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 339 shares — an estimated $224K sold.

Blueshift Asset Management first reported a position in CDLX in Q4 2020 and held it in 2 quarters. The position peaked at $370K in Q4 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

Blueshift Asset Management reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
Blueshift Asset Management sold 339 Cardlytics shares in Q1 2022, an estimated $224K.
Blueshift Asset Management first reported a position in Cardlytics in Q4 2020 and held it in 2 quarters.
Blueshift Asset Management's Cardlytics position peaked at $370K in Q4 2020.
153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Blueshift Asset Management's 13F filing for Q1 2022, filed 12 May 2022.